
Novo Nordisk has introduced oral versions of its popular weight-loss drugs Ozempic and Wegovy, now available for same-day delivery on Amazon. These once-daily pills follow the original weekly injectables and have quickly gained over one million users since launch. CEO Mike Doustdar highlighted the broader health benefits beyond weight loss and emphasized efforts to keep prices fair for wider patient access. The company is also developing a promising new drug for liver disease that could reduce the need for transplants.